Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Practice Point
Nature Reviews Endocrinology 2, 488–489 (1 September 2006) | doi:10.1038/ncpendmet0269
Does the metabolic activity of metastatic thyroid carcinoma correlate with prognosis?
Abstract
Robbins RJ et al. (2006) Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F] fluoro- 2-deoxy-D-glucose-positron emission tomography scanning. J Clin Endocrinol Metab 91: 498–505 Synopsis Background Prognosis of primary thyroid carcinoma is determined by use of pathologic and clinical data obtained at initial diagnosis; however, this strategy provides little information regarding the prognosis of subsequent distant metastases.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
